Gene | Controls, n=1743 (%) | Cases | |
---|---|---|---|
BOT, n=102 (%) | Ovarian cancer G1, n=167 (%) | ||
BRCA1 | 5 (0.29) | 0 (0.00) | 4 (2.40) |
OR (95% CI) p value | ref. | - | 8.53 (2.09–32.54) 0.005 |
BRCA2 | 0 (0.00) | 1 (0.98) | 1 (0.60) |
OR (95% CI) p value | ref. | - | - |
RAD51C | 3 (0.17) | 0 (0.00) | 0 (0.00) |
OR (95% CI) p value | ref. | - | - |
PALB2 | 3 (0.17) | 0 (0.00) | 2 (1.20) |
OR (95% CI) p value | ref. | - | 7.03 (0.92–42.72) 0.03 |
CHEK2 PTT | 10 (0.57) | 1 (0.98) | 1 (0.60) |
OR (95% CI) p value | ref. | 1.72 (0.09–9.09) 0.61 | 1.04 (0.06–5.5) 0.97 |
missense mutation (c.470T>C) OR (95% CI) p value | 97 (5.57) ref. | 11 (10.78) 2.05 (1.01–3.81) 0.03 | 13 (7.78) 1.43 (0.75–2.53) 0.24 |